Gilternib 40 Mg (Gilteritinib) – 90 Tablets

Gilternib 40 Mg (Gilteritinib) is a targeted therapy specifically designed for the treatment of acute myeloid leukemia (AML) in patients with FLT3 mutations. Containing Gilteritinib, Gilternib 40 mg works by inhibiting the FLT3 receptor tyrosine kinase, a protein that plays a crucial role in the proliferation and survival of leukemia cells. This targeted approach makes Gilternib particularly effective in managing AML, offering improved survival rates and quality of life for patients with FLT3 mutation-positive tumors.

Gilternib 40 mg is indicated for the treatment of:

• Acute Myeloid Leukemia (AML): Gilternib is used as a targeted therapy for adult patients with relapsed or refractory AML who have a FLT3 mutation. It is especially beneficial for patients who have not responded to prior treatments or who have relapsed after initial therapy.

Product Feature:

You will have the ability to order easily and pay the best price if you use Unit Pharmacy Website for buying Gilternib 40 Mg (Gilteritinib) medicine.